DMU2139

CAS No. 104890-70-2

DMU2139( —— )

Catalog No. M22628 CAS No. 104890-70-2

DMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 56 In Stock
5MG 81 In Stock
10MG 120 In Stock
25MG 215 In Stock
50MG 324 In Stock
100MG 486 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DMU2139
  • Note
    Research use only, not for human use.
  • Brief Description
    DMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).
  • Description
    DMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    CYP1B1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    104890-70-2
  • Formula Weight
    289.3
  • Molecular Formula
    C19H15NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc2cc(ccc2c1)C(=O)\C=C\c1cccnc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Horley N J , Beresford K J M , Chawla T , et al. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines[J]. European Journal of Medicinal Chemistry, 2017, 129:159-174.
molnova catalog
related products
  • N-desmethyl Olanzapi...

    N-desmethyl Olanzapine is a metabolite of the atypical antipsychotic compound Olanzapinec, which is formed through the oxidative metabolism of olanzapine by the cytochrome 450 (CYP) isoenzyme CYP1A2.

  • Tienilic Acid

    Tienilic Acid is a uricosuric diuretic with certain hepatotoxicity.

  • CYP1B1-IN-4

    CYP1B1-IN-4, a 2,4-diarylthiazole compound, exhibits selective inhibition of CYP1B1 (IC50=0.2 nM), demonstrating minimal cytotoxicity and high stability in human and rat liver microsomes .